Healthcare Value Chain Key to Boosting Pharma Exports

India's healthcare sector can enhance pharma exports by entering the global value chain, says Commerce Secretary.

Sunil Barthwal, Secretary, Union Ministry of Commerce and Industry suggests that integrating into the global value chain could further increase India's pharma exports ().

He said this during an interaction with pharma sector industry leaders at the ongoing three-day International Pharmaceutical Exhibition (IPHEX) jointly organized by the Pharmaceutical Export Promotion Council and the ministry.

3D Printing in the Pharmaceutical Industry: Technology and Future
3D printing technology of medicines in the pharmaceutical industry is an advanced drug delivery system that uses computer-aided designs to create personalized drugs.

‘ Did You Know?
Pharmaceutical companies invest an average of 15-20% of their revenues into research and development. #pharma #healthcare ’

“The Department of Commerce has included pharma as an important sector. By creating a healthcare sector value chain on the lines of the mobility chain created by the automobile industry, the exports of pharma products can increase in a big way,” said Barthwal.

He added said that “the mobility chain created by the automobile industry has included all component auto linked part manufacturers including tyre, engine, brakes, steel makers and other related parts”.

This, he said, helped in increasing exports and finding new markets.

Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a drug, reaction to a drug or drug abuse.

“Similarly, the pharma industry should include medical instrument manufacturers, diagnosis, hospitals, etc, and offer total packages to the world for both pre and post-health care at affordable prices. This can be done without losing the main focus of manufacturing pharma products,” the Secretary said.

He further noted that there are opportunities to increase pharmaceutical trade and provide affordable medicines and health care to many countries, including in Africa.“Pharma should also look at emerging markets.

Pharmacovigilance - The Key to Drug Safety
Pharmacovigilance refers detecting and reporting adverse drug reactions, thereby ensuring patient safety.

India's Pharma Exports Could Soar with Global Value Chain Integration

Worldwide over including in the US, the debate is going on for moving towards affordable medicines and removing trade barriers and product patents,” Barthwal said.

He also mentioned the Free Trade Agreement (FTA) that India is signing with many countries and other measures like “stopping a fresh trial system for the US FDA-approved products”.

Drug Dependence and Abuse
Substance abuse and dependence refer to the excessive and harmful use of substances, causing physical, mental, and social damage, manifested through specific harmful signs and symptoms.

Removing these technical barriers can help create “a free level playing field for Indian companies as per WTO rules”, the Secretary noted.

At the IPHEX 2024, more than 400 major Indian pharma companies will showcase their pharmaceutical products and technologies at the expo. More than 400 foreign buyers from across the world are expected to attend.

Reference:

International Pharmaceutical Exhibition (IPHEX) - (https://www.iphex-india.com/)

Source-IANS